Is Alvotech (ALVO) Stock Outpacing Its Medical Peers This Year?

Zacks
12 Dec 2024

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Alvotech (ALVO) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.

Alvotech is one of 1022 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Alvotech is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for ALVO's full-year earnings has moved 54.7% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, ALVO has moved about 0.6% on a year-to-date basis. At the same time, Medical stocks have lost an average of 0.5%. This means that Alvotech is outperforming the sector as a whole this year.

Twist Bioscience (TWST) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 32.6%.

The consensus estimate for Twist Bioscience's current year EPS has increased 10.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, Alvotech belongs to the Medical - Biomedical and Genetics industry, which includes 502 individual stocks and currently sits at #62 in the Zacks Industry Rank. On average, this group has lost an average of 7.2% so far this year, meaning that ALVO is performing better in terms of year-to-date returns. Twist Bioscience is also part of the same industry.

Investors interested in the Medical sector may want to keep a close eye on Alvotech and Twist Bioscience as they attempt to continue their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alvotech (ALVO) : Free Stock Analysis Report

Twist Bioscience Corporation (TWST) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10